In contrast, activation of the CXCR4 seemed to have positive effects on such systemic and acute diseases as sepsis or polytrauma and, there is evidence that in vivo treatment with CXCL12 analogs results in improved survival [15,16]. The gene discussed is CXCL12; the disease is Sepsis.